Current Seminars
26/02/2013 - 18:30 -
“This house believes the government should play a more active role in the direction of food and nutrition choices of its citizens”.
The motion: “This house believes the government should play a more active role in the direction of the food and nutrition choices of its citizens”.
Find out next week what MBiotech students think.
For the motion: Team NovoVit Inc.
Against the motion: Team Innologix...
19/02/2013 - 18:30 -
Direct to Consumer Pharmaceutical Advertising (DTCPA) benefits patients.
The motion: "This house believes that Direct to Consumer Pharmaceutical Advertising (DTCPA) benefits patients."
Should pharmaceutical companies be allowed to conduct branded and unbranded advertising directly to patients? Does the patient ultimately benefit from DTCPA when the bottom line of pharmaceutical companies is to drive sales of...
12/02/2013 - 18:30 -
Clinical trials involving a placebo arm are unethical
The motion: "This house believes that clinical trials involving a placebo arm are unethical."
Does conducting a clinical trial with a placebo violate a code of ethics? If the treatment option that is being tested shows improved outcomes in patients, is it unethical not to treat the placebo group with the novel ...
05/02/2013 - 18:30 -
Investing in entrepreneurial life science companies in Canada.
Tuesday, February 5th, 2013, 6.30pm-8.00pm. Instructional Centre, Room 120. Open to the public.
Brian Bloom, President and Head of Institutional Sales and capital market activities at Bloom Burton & Co.
The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this...
29/01/2013 - 18:30 -
Steps and Issues in Filing A Trademark
Tuesday, January 29th, 2013, 6.30pm-8.00pm. Instructional Centre, Room 120. Open to the public.
Professor Ariel Katz, Faculty of Law, University of Toronto
The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar...